Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment; Groundbreaking preclinical research highlights therapeutic potential of targeting the mechanical barrier in treat

Press/Media: Expert Comment

PeriodNov 3 2021

Media coverage

1

Media coverage

  • TitleParthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment; Groundbreaking preclinical research highlights therapeutic potential of targeting the mechanical barrier in treat
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date11/3/21
    PersonsRong Li